Ke Wu1, Yan Cong2. 1. Prenatal Diganosis Center, Yiwu Maternity and Child Health Care Hospital, Xinke Road C100, Yiwu, 322000, Zhejiang Province, People's Republic of China. 2. Rehabilitation Department, Yiwu Maternity and Child Health Care Hospital, Xinke Road C100, Yiwu, 322000, Zhejiang Province, People's Republic of China. 2825583487@qq.com.
Abstract
BACKGROUND: Bainbridge-Ropers syndrome (BRPS) [OMIM#615485] is a neurodevelopmental disorder, characterized by delayed psychomotor development with generalized hypotonia, moderate to severe intellectual disability, poor or absent speech, feeding difficulties, growth failure, dysmorphic craniofacial features and minor skeletal features. The aim of this study was to investigate the genetic etiology of a Sudanese boy with severe developmental delay, intellectual disability, and craniofacial phenotype using trio-based whole-exome sequencing. To our knowledge, no patients with ASXL3 gene variant c.3043C>T have been reported detailedly in literature. CASE PRESENTATION: The patient (male, 3 years 6 months) was the first born of a healthy non-consanguineous couple originating from Sudan, treated for "psychomotor retardation" for more than 8 months in Yiwu. The patient exhibited severely delayed milestones in physiological and intellectual developmental stages, language impairment, poor eye-contact, lack of subtle motions of fingers, fear of claustrophobic space, hypotonia, clinodactyly, autistic features. Peripheral blood samples were collected from the patient and his parents. Trio-based whole-exome sequencing(Trio-WES) identified a de novo heterozygous ASXL3 gene variant c.3043C>T;p.Q1015X. Sanger sequencing verified variants of this family. CONCLUSION: Trio-WES analysis identified a de novo nonsense variant (c.3043C>T) of ASXL3 gene in a Sudanese boy. To our knowledge, the patient with this variant has not been reported previously in literature. This study presents a new case for ASXL3 gene variants, which expanded the mutational and phenotypic spectrum.
BACKGROUND: Bainbridge-Ropers syndrome (BRPS) [OMIM#615485] is a neurodevelopmental disorder, characterized by delayed psychomotor development with generalized hypotonia, moderate to severe intellectual disability, poor or absent speech, feeding difficulties, growth failure, dysmorphic craniofacial features and minor skeletal features. The aim of this study was to investigate the genetic etiology of a Sudanese boy with severe developmental delay, intellectual disability, and craniofacial phenotype using trio-based whole-exome sequencing. To our knowledge, no patients with ASXL3 gene variant c.3043C>T have been reported detailedly in literature. CASE PRESENTATION: The patient (male, 3 years 6 months) was the first born of a healthy non-consanguineous couple originating from Sudan, treated for "psychomotor retardation" for more than 8 months in Yiwu. The patient exhibited severely delayed milestones in physiological and intellectual developmental stages, language impairment, poor eye-contact, lack of subtle motions of fingers, fear of claustrophobic space, hypotonia, clinodactyly, autistic features. Peripheral blood samples were collected from the patient and his parents. Trio-based whole-exome sequencing(Trio-WES) identified a de novo heterozygous ASXL3 gene variant c.3043C>T;p.Q1015X. Sanger sequencing verified variants of this family. CONCLUSION: Trio-WES analysis identified a de novo nonsense variant (c.3043C>T) of ASXL3 gene in a Sudanese boy. To our knowledge, the patient with this variant has not been reported previously in literature. This study presents a new case for ASXL3 gene variants, which expanded the mutational and phenotypic spectrum.
Bainbridge-Ropers syndrome (BRPS) is a severe neurodevelopmental disorder characterized by failure to thrive, severe developmental delay, intellectual disability, and craniofacial phenotype. BRPS is caused by a heterozygous loss-of-function mutation in ASXL3 gene. With the use of trio-based whole-exome sequencing, we reported a Sudanese boy with a novel pathogenic variant in ASXL3 gene. We described clinical abnormalities, medical imaging and genetic characteristics of this disease to improve the comprehensive understanding of BRPS for pediatricians.
Case presentation
The patient (male, 3 years 6 months) was born of a healthy non-consanguineous couple originating from Sudan, treated for “psychomotor retardation” for more than 8 months in Yiwu. Family history was unremarkable. At 37 weeks, the patient was born in the first child of his mother by cesarean delivery. The mother denied the history of birth asphyxia and intracranial hemorrhage. The mother’s pregnancy was abnormal with hypothyroidism and gestational diabetes mellitus. There was no exposure to alcohol, tobacco, or drugs. In the 29th week of gestation, ultrasonography indicated scaphocephaly (scaphocephaly occurs when there is a premature fusion of the sagittal suture) (Fig. 1). The birth weight was 2.66 kg and length was 32 cm. After breast-fed up for 3 months, the patient presented feeding difficulties. At 11 months of age, the patient could not lift his head. Three-dimensional CT imaging showed premature fusion of cranial suture, microcephaly and trigoncephaly (Fig. 2), then the patient received craniostenosis surgery (extensive cranioplasty for sagittal synostosis by preserving cranial bone flaps adhered to the dura mater) [1] in Hainan children’s hospital. One month after surgery, the patient was transferred to our hospital for rehabilitation. The results of action observation training (AOT) and goal-directed training (GDT) showed promising.
Fig. 1
The 29th week of gestation, the fetus with scaphocephaly. Axial view of the fetal head (H) showed a long (arrowheads) and narrow head (arrows)
Fig. 2
a-c at 11 months of age, three-dimensional CT imaging of the patient
The 29th week of gestation, the fetus with scaphocephaly. Axial view of the fetal head (H) showed a long (arrowheads) and narrow head (arrows)a-c at 11 months of age, three-dimensional CT imaging of the patientAt 3 years 6 months of age, the patient had a weight of 8.0 kg(< 3rd percentile), a length of 50 cm and an occipital frontal circumference (OFC) of 43.8cm(< 3rd percentile). The patient exhibited severely delayed milestones in physiological and intellectual developmental stages(IQ<50), language impairment, poor eye-contact, lack of subtle motions of fingers, fear of claustrophobic space, hypotonia, clinodactyly. He had autistic features as not playing with other children of his own age and a narrow range of interests. He had obvious self-harm behavior, manifested as head banging. At present, the patient could lift his head, roll over, but could not crawl or stand on four limbs. He was able to sit alone without support for only moments. He could not make a fist. In the supine position, he had active grasp consciousness, could grasp cubes using the ulnar-palmar grasp technique; but in the sitting prone position, he couldn’t do these. His eyes could not track objects, and he had no response to sound or simple verbal commands. He could not says simple words, such as "Mama" and "Dada". Bilateral patellar reflex was present, Babinski reflex was negative, step reflex was not induced. He has facial dimorphism (Fig. 3), including microcephaly, strabismus, widely spaced eyes, epicanthal folds, highly arched eyebrows, long lashes, depressed nasal ridge, crowded teeth, thin upper lip vermillion, hirsutism, posteriorly rotated ear, anteverted nares, and palate malformations. The brain interictal electroencephalogram (EEG) showed normal and magnetic resonance imaging (MRI) indicated that the vascular space in the posterior horn of the ventricle was widened (Fig. 4).
Fig. 3
a-b microcephaly, strabismus, widely spaced eyes, epicanthal folds, highly arched eyebrows, long lashes, depressed nasal ridge, crowded teeth, thin upper lip vermillion, hirsutism, posteriorly rotated ear, anteverted nares, and palate malformations. c the hand were relaxed, not clawed. d the feet clenched like fists
Fig. 4
at 3 years 6 months of age, brain MRI of the patient indicated that the vascular space in the posterior horn of the ventricle was widened
a-b microcephaly, strabismus, widely spaced eyes, epicanthal folds, highly arched eyebrows, long lashes, depressed nasal ridge, crowded teeth, thin upper lip vermillion, hirsutism, posteriorly rotated ear, anteverted nares, and palate malformations. c the hand were relaxed, not clawed. d the feet clenched like fistsat 3 years 6 months of age, brain MRI of the patient indicated that the vascular space in the posterior horn of the ventricle was widened
Neuropsychological scores
The Griffiths mental development scales for China (GDS-C) are used to assess the development of children from birth to 8 years across six separate subscales: locomotor (A), personal-social (B), language (C), eye-hand co-ordination (D), performance (E) and practical reasoning (F). Developmental curves with respect to all the six subscales together with the “general quotient”(GQ) were plotted. The GQ was derived by calculating the average of the raw scores of the six subscales. The raw scores of the six subscales were converted to the corresponding percentiles. The 1st, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 99th percentiles(the percentile graphs demonstrated normative trends in developmental scores)were displayed in each plot [2]. The patient had a GQ of 16.25. (The raw scores of the five subscales were lower than 1st percentile, the score of subscale F was not finished due to the child could not cooperate)The childhood autism rating scale (CARS) is widely used by psychiatrists for identifying children with autistic spectrum disorder (ASD). The CARS score of the patient was 45 [not autistic < 30, mild or moderately autistic (30-36.5) or severely autistic > 36.5] [3].The screening tool for autism in toddlers and young children (STAT )[4] is a Level 2 screening measure for children between 24 and 36 months and consists of 12 activity-based items that assess a range of socialcommunicative behaviors. The patient obtained a STAT score of 3.0 (a score greater than or equal to the cutoff (1.75) indicates autism risk).
Genetic tests and laboratory examination
Parents signed an informed consent for genetic analysis. Our legal ethics committee approved this genetic study. DNA isolated from peripheral blood cells was enriched for trio-WES and Sanger sequencing was used for verification. The patient was screened for genetic metabolic disease, chromosome karyotyping, and copy number variation (CNV). Levels of urine organic acids, plasma amino acids, blood gas analysis, lactate, pyruvic acid and thyroid function were normal. Conventional G-banded chromosome analysis showed a 46,XY karyotype.The patient was examined using a multi-step molecular diagnostics algorithm, including genetic metabolic disease, chromosome karyotyping, and CNV with negative results. Trio-based whole-exome sequencing identified a de novo heterozygous ASXL3 gene variant c.3043C>T;p.Q1015X(NM_030632.3)(Table 1). This variant has not been reported in the dbSNP, gnomAD, the 1,000 Genomes Project, Exome Aggregation Consortium and Exome Variant Server. The de novo status was independently confirmed by Sanger sequencing of parents (Fig. 5).
Table 1
Genomic findings and variant interpretation
Gene
Genomic location
HGVS cDNA
HGVS protein
Zygosity
Parent of origin
Interpretation
ASXL3
Chr18:31322918 C>T(GRCh37)
c.3043C>T (NM_030632.3)
p.Q1015X
Het
De novo
Pathogenic (PVS1,PS2, PM2,PP4,PP5)
Criteria: PVS1: null variant; PS2: de novo in a patient with disease and no family history; PM2: absent from controls; PP4: patient’s phenotype is highly specific for a disease with a single genetic etiology; PP5: reputable source recently reports the variant as likely pathogenic, but evidence was not available for us to perform an independent evaluation.
Fig. 5
a-c Sanger sequencing of the patient and parents a, A de novo heterozygous ASXL3 gene variant c.3043C>T;p.Q1015X(NM_030632.3) in the patient. b, Not found in his father. c, Not found in his mother. The frame indicates the location of the variant
Genomic findings and variant interpretationCriteria: PVS1: null variant; PS2: de novo in a patient with disease and no family history; PM2: absent from controls; PP4: patient’s phenotype is highly specific for a disease with a single genetic etiology; PP5: reputable source recently reports the variant as likely pathogenic, but evidence was not available for us to perform an independent evaluation.a-c Sanger sequencing of the patient and parents a, A de novo heterozygous ASXL3 gene variant c.3043C>T;p.Q1015X(NM_030632.3) in the patient. b, Not found in his father. c, Not found in his mother. The frame indicates the location of the variant
Discussion and conclusions
Bainbridge-Ropers syndrome (BRPS) is inherited in an autosomal dominant model and was first described in 2013. Bainbridge et al [5] reported de novo truncating mutations in ASXL3 in four unrelated probands with psychomotor retardation, failure to thrive, feeding difficulties, language delay and dysmorphic craniofacial features.To date, more than 30 cases were described in literature [6]. The clinical phenotype of the Sudanese boy has not showed morbid obesity [2], generalized epilepsy [7], undescended testes[8], nystagmus [9], pontocerebellar hypoplasi a[10], hypoplasia of corpus callosum [11], nystagmus [12], which described previously in Bainbridge-Ropers syndrome. Mutations in ASXL3 may also cause congenital hypothyroidism [13] and autosomal recessive congenital heart disease [14].The ASXL transcriptional regulator 3 (ASXL3) gene is located at the 18q12.1 chromosome region and encodes putative polycomb group protein ASXL3. ASXL3 contains a plant homeodomain (PHD) zinc finger domain, which is a member of the vertebrate ASX-like protein family playing a role in the regulation of gene transcription. Protein ASXL3 expressed mainly in brain, testis and ovary [15]. This transcript of ASXL3(NM_030632.3) has 12 coding exons, transcript length of 11,760 bps, and translation length of 2,248 residues.To our knowledge, no patients with this variant have been reported detailedly in literature. We interpret c.3043C>T(p.Q1015X) as a pathogenic variant. The variant causes a premature termination codon, resulting in the strong protein truncation (more than 50% of protein length is missing).For now, the number of variants reported in literature and our study is 37. Except for one splicing variant, all of them are nonsense and frameshift variants, which are mostly located in two mutational cluster regions (MCRs) distributed in the 5’ end of exon 11 and exon 12 respectively [16]. These variants reported thus far are predicted to result in protein truncation and are prone to nonsense mediated decay, with the resultant reduction in the expression of ASXL3. Thus haploinsufficiency may represent the mechanism of Bainbridge-Ropers syndrome.In the previous literature, no patients with BRPS received craniostenosis surgery. There are no reports of BRPS in Sudanese with de novo truncating mutations. This study expands the clinical phenotype of BRPS and ASXL3 gene mutational spectrum.In summary, we identified a novel heterozygous ASXL3 gene variant c.3043C>T(p.Q1015X) in a Sudanese family, which had not been reported previously. The clinical phenotype like feeding difficulties, intellectual disability, failure to thrive, and craniofacial features in children are always difficult to distinguish. Whole-exome sequencing is a useful tool for precise diagnosis, carrier screening and genetic counselling. The skull of young children is relatively thin and early surgery can easily achieve satisfactory bone reshaping avoiding skull deformity. Such surgical technique could be considered for these patients if necessary.
Authors: M Balasubramanian; J Willoughby; A E Fry; A Weber; H V Firth; C Deshpande; J N Berg; K Chandler; K A Metcalfe; W Lam; D T Pilz; S Tomkins Journal: J Med Genet Date: 2017-01-18 Impact factor: 6.318
Authors: Alma Kuechler; Johanna Christina Czeschik; Elisabeth Graf; Ute Grasshoff; Ulrike Hüffmeier; Tiffany Busa; Stefanie Beck-Woedl; Laurence Faivre; Jean-Baptiste Rivière; Ingrid Bader; Johannes Koch; André Reis; Ute Hehr; Olaf Rittinger; Wolfgang Sperl; Tobias B Haack; Thomas Wieland; Hartmut Engels; Holger Prokisch; Tim M Strom; Hermann-Josef Lüdecke; Dagmar Wieczorek Journal: Eur J Hum Genet Date: 2016-11-30 Impact factor: 4.246
Authors: W W Y Tso; V C N Wong; X Xia; B Faragher; M Li; X Xu; L Ao; X Zhang; F-Y Jiao; K Du; X Shang; P T Y Wong; D Challis Journal: Child Care Health Dev Date: 2018-02-01 Impact factor: 2.508
Authors: Daniel C Koboldt; Theresa Mihalic Mosher; Benjamin J Kelly; Emily Sites; Dennis Bartholomew; Scott E Hickey; Kim McBride; Richard K Wilson; Peter White Journal: Cold Spring Harb Mol Case Stud Date: 2018-06-01
Authors: Matthew N Bainbridge; Hao Hu; Donna M Muzny; Luciana Musante; James R Lupski; Brett H Graham; Wei Chen; Karen W Gripp; Kim Jenny; Thomas F Wienker; Yaping Yang; V Reid Sutton; Richard A Gibbs; H Hilger Ropers Journal: Genome Med Date: 2013-02-05 Impact factor: 11.117